Grant: Project Grant
University of Saskatchewan
$772,650.00
Regulation of intestinal lipid storage and release in metabolic health and disease
EF 2023-24
Résumé
The number of patients with metabolic diseases (diabetes, obesity, and metabolic syndrome) is high and continues to rise in Canada and world-wide. A serious consequence of these chronic diseases is high levels of bad blood fats that cause heart disease and strokes. Improper fat handling in the gut leads to high levels of bad blood fats. We propose to systemically investigate how fats are handled in the gut in health and in metabolic diseases. Manufacturing and transport of fat particles in the gut at the cell, organ and whole-body levels will be studied in rats in health and disease conditions. Fat particle output in the gut will be measured, along with changes in proteins in cell organelles, cells, and tissues. These studies will help identify the control points of fat processing in the gut, understand what goes wrong in disease conditions, and develop novel ways towards treating abnormal blood fats and reducing the risks of heart disease and strokes in a very large population of patients.
Programme
Project Grant
Bénéficiaire
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
488397
Name
Xiao Changting
Region
Saskatchewan
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Diabetes, Obesity, Lipid & Lipoprotein Disorders
Projecttitle
Regulation of intestinal lipid storage and release in metabolic health and disease
Programtype2
Operating Grants
Orgnameinp2
University of Saskatchewan
Cihramount2
$772,650
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Animal; Dyslipidemia; Hormones; In Vivo; Integrative Physiology; Intestine; Lipids And Lipoproteins; Metabolism And Metabolic Disorders
Abstract
The number of patients with metabolic diseases (diabetes, obesity, and metabolic syndrome) is high and continues to rise in Canada and world-wide. A serious consequence of these chronic diseases is high levels of bad blood fats that cause heart disease and strokes. Improper fat handling in the gut leads to high levels of bad blood fats. We propose to systemically investigate how fats are handled in the gut in health and in metabolic diseases. Manufacturing and transport of fat particles in the gut at the cell, organ and whole-body levels will be studied in rats in health and disease conditions. Fat particle output in the gut will be measured, along with changes in proteins in cell organelles, cells, and tissues. These studies will help identify the control points of fat processing in the gut, understand what goes wrong in disease conditions, and develop novel ways towards treating abnormal blood fats and reducing the risks of heart disease and strokes in a very large population of patients.
Competitiondate
202309
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Xiao, Changting
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $772,650~ $0~